• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Indium In-111 Product Approval Information - New Drug Application 2/19/02 (Supp 003)

Product name: Indium In-111 Chloride Solution
Manufacturer: Mallinckrodt, Inc, St. Louis, MO
Indication for Use: Use in radiolabeling Ibritumomab Tiuxetan (Zevalin) and remove use in radiolabeling Imciromab Pentetate (Myoscint)
Approval Date: 2/19/2002
Type of submission: New Drug Application Supplement


Approval Letter (PDF)

Label - (PDF)